Asia's most strategic convention for vaccine stakeholders

Dr Xu Fei has over 10 years experience in biopharmaceutical research and project management. She got her Ph.D from Max-Planck Institute for Polymer Research (Germany). After being awarded Doctor, she has worked first in Institute of Materials Research and Engineering (A

Mr. Klaus Hermansen is Senior Technology Partner within the Business Development Group in NNE Pharmaplan, a global engineering and consulting company providing projects and services for biotech and pharmaceutical companies worldwide. He holds a Master’s degree in Biote…more ›

Education: 1988: M.S. Life-chemistry in Graduate school Tokyo Institute of Technology 1997: Ph.D. Tokyo Institute of Technology Work experience: 1988-2000: Research scientist Pharmaceutical laboratory KIRIN brewery 1993-1996: Research scientist Immunochemistry (Prof.…more ›

Professor Jin-Han Kang obtained doctoral degree from The Catholic University of Korea in 1990 after graduation from the College of Medicine of the same university in 1977. After Professor Kang completed internship and residency in the St. Mary's Hospital, he moved …more ›

Dr Phil Kearney joined Merck Sharp & Dohme Australia in 2007 as the key scout for innovative research and development in Australia, New Zealand and some parts of South East Asia. The Sydney-born scientist has the challenge of uncovering and commercialising discoveri…more ›

Francisco Leon, MD PhD, Vice President and Head of Immunology Translational Medicine at Janssen R&D (formerly Centocor), Pharmaceutical Companies of Johnson & Johnson, is a clinical immunologist who received his MD from Autónoma University in Madrid, Spain

Mick Martin has joined Bavarian Nordic as the Regional Director for government projects across Asia Pacific (APAC). He coordinates Bavarian Nordic’s efforts with its strategic partners to bring value to government CBRN programs. Bavarian Nordic is a leading industrial …more ›

Professor Alex Matter, M.D., is CEO of the Experimental Therapeutics Centre, A*STAR, Singapore, having spent five and a half years as Director of the Novartis Institute for Tropical Diseases (NITD), from October 2003 to February 2009. Prior to this role, Dr. Matter was

Mr. Ors has more than ten years of experience in Licensing, Intellectual Property and business development in biotechnology. He joined Medicago in 2001 and oversees Business Development activities. He is also responsible for securing Medicago's Freedom to Operate an…more ›

Nikolai is Director of Endocrinology at Flinders Medical Centre and Professor of Medicine at Flinders University. He is also founder of Vaxine Pty Ltd, a company developing novel vaccine technologies. In pursuit of vaccines to protect against multiple biodefense threats

Dr. S.D. Ravetkar is Executive Director with Serum Institute of India Ltd. Apart from his Doctorate he holds degrees in Management and Finance. He has authored various research articles in national and international journals. He is also on advisory board of various nati…more ›

I serve as Executive Vice President of AnGes MG, as well as President/CEO of Its US operation, directing all aspects of company’s US business and R&D activities. Prior to joining AnGes, spent 28 years with Sumitomo Pharmaceuticals(now Dainippon Sumitomo Pharmaceutic…more ›

Lawrence Segal is Director of Nonclinical Toxicology and Pharmacology in the Global RA department of GSK Vaccines in Wavre, Belgium, where he is responsible for the preparation, coordination and approval of the nonclinical toxicology and pharmacology sections of dossie…more ›

Dr Klaus Stöhr is Vice President, Global Head Policy in Novartis Vaccines and Diagnostics. Dr Stöhr completed his PhD at the University of Leipzig in 1987, as a research fellow in the Department for Epidemiology and Veterinary Public Health. After leaving acad

Dr. Yun-Ling Wong currently serves as a Program Officer in the Global Health Program Discovery and Translational Sciences team. In this capacity, she leads the Grand Challenges Explorations Initiative. This $200M initiative is dedicated to identify and foster innovators…more ›